Enovis (ENOV) Stock Forecast & Price Target

Compare

264 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ENOV Analyst Ratings

Strong Buy

8 Buy

2 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Enovis

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ENOV Stock 12 Month Forecast

Average Price Target

$49.56

▲(71.96% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Enovis in the last 3 months. The average price target is $49.56 with a high forecast of $75.00 and a low forecast of $29.00. The average price target represents a 71.96% change from the last price of $28.82.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"24":"$24","37":"$37","50":"$50","63":"$63","76":"$76"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$75.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":49.56,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$49.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$29.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[24,37,50,63,76],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.74,29.529230769230768,33.318461538461534,37.107692307692304,40.89692307692307,44.68615384615384,48.47538461538461,52.26461538461538,56.05384615384615,59.84307692307692,63.63230769230769,67.42153846153846,71.21076923076923,{"y":75,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.74,27.572307692307692,29.404615384615383,31.236923076923077,33.06923076923077,34.901538461538465,36.73384615384616,38.566153846153846,40.39846153846154,42.23076923076923,44.06307692307692,45.895384615384614,47.72769230769231,{"y":49.56,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.74,25.990769230769228,26.24153846153846,26.49230769230769,26.743076923076924,26.993846153846153,27.244615384615383,27.495384615384616,27.746153846153845,27.996923076923075,28.247692307692308,28.498461538461537,28.74923076923077,{"y":29,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":46.54,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.6,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.47,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.43,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49.33,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.88,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.98,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.65,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.18,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.6,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.65,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.02,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.74,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$75.00

Average Price Target$49.56

Lowest Price Target$29.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Garrick Presswyn

TR | OpenAI - 4o

$28→$29

Hold

0.62%

Upside

Reiterated

08/14/25

AI Generated ArticleAI Generated Article

Caitlin Cronin

Canaccord Genuity

$58

Buy

101.25%

Upside

Reiterated

08/13/25

Enovis: Strategic Positioning and Growth Potential Justify Buy Rating

Robbie Marcus

J.P. Morgan

$33

Hold

14.50%

Upside

Reiterated

08/08/25

Analysts' Top Healthcare Picks: DENTSPLY SIRONA (XRAY), Replimune Group (REPL)

Jason Wittes

Roth MKM

$75

Buy

160.24%

Upside

Reiterated

08/08/25

Enovis (ENOV) Gets a Buy from Roth MKM

Danielle Antalffy

UBS

$65→$57

Buy

97.78%

Upside

Reiterated

08/08/25

Enovis price target lowered to $57 from $65 at UBSEnovis price target lowered to $57 from $65 at UBS

Vik Chopra

Wells Fargo

$48→$41

Buy

42.26%

Upside

Reiterated

08/08/25

Wells Fargo Sticks to Its Buy Rating for Enovis (ENOV)

Vijay Kumar

Evercore ISI

$46→$44

Buy

52.67%

Upside

Reiterated

08/07/25

Evercore ISI Reaffirms Their Buy Rating on Enovis (ENOV)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

08/07/25

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (NASDAQ: PRCT) and Enovis (NYSE: ENOV)

Michael Matson

Needham

$57→$49

Buy

70.02%

Upside

Reiterated

08/07/25

Enovis: Strong Financial Performance and Positive Outlook Justify Buy Rating

Young Li

Jefferies

$60

Buy

108.19%

Upside

Reiterated

05/30/25

Optimistic Buy Rating for Enovis: Strong Growth, Margin Expansion, and Attractive Valuation

David Turkaly

Citizens JMP

$62→$55

Buy

90.84%

Upside

Reiterated

05/09/25

Enovis price target lowered to $55 from $62 at Citizens JMPEnovis price target lowered to $55 from $62 at Citizens JMP

Jeff Johnson

Robert W. Baird

$64

Buy

122.07%

Upside

Reiterated

11/06/24

Enovis: Strong Market Position and Growth Potential Justify Buy Rating

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Garrick Presswyn

TR | OpenAI - 4o

$28→$29

Hold

0.62%

Upside

Reiterated

08/14/25

AI Generated ArticleAI Generated Article

Caitlin Cronin

Canaccord Genuity

$58

Buy

101.25%

Upside

Reiterated

08/13/25

Enovis: Strategic Positioning and Growth Potential Justify Buy Rating

Robbie Marcus

J.P. Morgan

$33

Hold

14.50%

Upside

Reiterated

08/08/25

Analysts' Top Healthcare Picks: DENTSPLY SIRONA (XRAY), Replimune Group (REPL)

Jason Wittes

Roth MKM

$75

Buy

160.24%

Upside

Reiterated

08/08/25

Enovis (ENOV) Gets a Buy from Roth MKM

Danielle Antalffy

UBS

$65→$57

Buy

97.78%

Upside

Reiterated

08/08/25

Enovis price target lowered to $57 from $65 at UBSEnovis price target lowered to $57 from $65 at UBS

Vik Chopra

Wells Fargo

$48→$41

Buy

42.26%

Upside

Reiterated

08/08/25

Wells Fargo Sticks to Its Buy Rating for Enovis (ENOV)

Vijay Kumar

Evercore ISI

$46→$44

Buy

52.67%

Upside

Reiterated

08/07/25

Evercore ISI Reaffirms Their Buy Rating on Enovis (ENOV)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

08/07/25

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (NASDAQ: PRCT) and Enovis (NYSE: ENOV)

Michael Matson

Needham

$57→$49

Buy

70.02%

Upside

Reiterated

08/07/25

Enovis: Strong Financial Performance and Positive Outlook Justify Buy Rating

Young Li

Jefferies

$60

Buy

108.19%

Upside

Reiterated

05/30/25

Optimistic Buy Rating for Enovis: Strong Growth, Margin Expansion, and Attractive Valuation

David Turkaly

Citizens JMP

$62→$55

Buy

90.84%

Upside

Reiterated

05/09/25

Enovis price target lowered to $55 from $62 at Citizens JMPEnovis price target lowered to $55 from $62 at Citizens JMP

Jeff Johnson

Robert W. Baird

$64

Buy

122.07%

Upside

Reiterated

11/06/24

Enovis: Strong Market Position and Growth Potential Justify Buy Rating

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Enovis

1 Month

xxx

Success Rate

6/12 ratings generated profit

Average Return

-0.53%

reiterated a xxx

rating 9 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -0.53% per trade.

3 Months

xxx

Success Rate

8/20 ratings generated profit

Average Return

-3.56%

reiterated a xxx

rating 8 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -3.56% per trade.

1 Year

Jeff JohnsonRobert W. Baird

Success Rate

2/13 ratings generated profit

Average Return

-16.61%

reiterated a buy rating 9 months ago

Copying Jeff Johnson's trades and holding each position for 1 Year would result in 15.38% of your transactions generating a profit, with an average return of -16.61% per trade.

2 Years

xxx

Success Rate

1/12 ratings generated profit

Average Return

-35.24%

reiterated a xxx

rating 9 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 8.33% of your transactions generating a profit, with an average return of -35.24% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ENOV Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ENOV has received 10 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. ENOV average Analyst price target in the past 3 months is 49.56.

Each month's total comprises the sum of three months' worth of ratings.

ENOV Financial Forecast

ENOV Earnings Forecast

Next quarter’s earnings estimate for ENOV is $0.65 with a range of $0.61 to $0.67. The previous quarter’s EPS was $0.79. ENOV beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 41.79% of the time in the same period. In the last calendar year ENOV has Outperformed its overall industry.

ENOV Sales Forecast

Next quarter’s sales forecast for ENOV is $538.51M with a range of $533.44M to $546.77M. The previous quarter’s sales results were $564.54M. ENOV beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 39.23% of the time in the same period. In the last calendar year ENOV has Outperformed its overall industry.

ENOV Stock Forecast FAQ

What is ENOV’s average 12-month price target, according to analysts?

Based on analyst ratings, Enovis’s 12-month average price target is 49.56.

What is ENOV’s upside potential, based on the analysts’ average price target?

Enovis has 71.96% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ENOV a Buy, Sell or Hold?

Enovis has a consensus rating of Strong Buy which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.

What is Enovis’s price target?

The average price target for Enovis is 49.56. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $75.00 ,the lowest forecast is $29.00. The average price target represents 71.96% Increase from the current price of $28.82.

What do analysts say about Enovis?

Enovis’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of ENOV?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Enovis (ENOV) Stock Forecast & Price Target

ENOV Analyst Ratings

ENOV Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Enovis

ENOV Analyst Recommendation Trends

ENOV Financial Forecast

ENOV Earnings Forecast

ENOV Sales Forecast

ENOV Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts